- Home
- PVLA vs NVRI Comparison
PVLA vs NVRI Comparison
Compare PVLA & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PVLA | NVRI |
|---|---|---|
| Founded | 2015 | 1853 |
| Country | United States | United States |
| Employees | 29 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 2026 |
Fundamental Metrics
Financial Performance| Metric | PVLA | NVRI |
|---|---|---|
| Price | $144.13 | $23.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $171.87 | N/A |
| AVG Volume (30 Days) | 290.1K | ★ 446.8K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.87 |
| Revenue Next Year | $104,350.18 | $3.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.19 | $7.70 |
| 52 Week High | $161.38 | $23.56 |
Technical Indicators
Market Signals| Indicator | PVLA | NVRI |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 60.96 |
| Support Level | $106.07 | $17.79 |
| Resistance Level | $156.28 | $23.56 |
| Average True Range (ATR) | 10.13 | 1.07 |
| MACD | 1.21 | 0.06 |
| Stochastic Oscillator | 65.47 | 88.30 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.